Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the efficacy of TAS-118 plus Oxaliplatin compared
with S-1 plus Cisplatin in overall survival in patients with advanced gastric cancer.